Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Influence of Pluronic F127 microenvironments on the photochemical nitric oxide release from S-nitrosoglutathione.

Picheth GF, Marini TC, Taladriz-Blanco P, Shimamoto GG, Dos Santos GJVP, Meneau F, de Oliveira MG.

J Colloid Interface Sci. 2019 May 15;544:217-229. doi: 10.1016/j.jcis.2019.02.087. Epub 2019 Feb 26.

PMID:
30849619
2.

Phase behavior of cholesterol in mixtures with hypo- and hypercholesterolemic lipids.

Esperança ES, Bonatto MS, Shimamoto GG, Tubino M, Costa MC, Meirelles AJA, Maximo GJ.

Food Funct. 2018 Jun 20;9(6):3447-3455. doi: 10.1039/c8fo00370j.

PMID:
29877525
3.

Simultaneous determination of six quality parameters of biodiesel through 1H NMR spectroscopy and partial least squares.

Shimamoto GG, Tubino M.

Talanta. 2018 Mar 1;179:816-821. doi: 10.1016/j.talanta.2017.12.001. Epub 2017 Dec 6.

PMID:
29310312
4.

Alternative method to quantify biodiesel and vegetable oil in diesel-biodiesel blends through 1H NMR spectroscopy.

Shimamoto GG, Bianchessi LF, Tubino M.

Talanta. 2017 Jun 1;168:121-125. doi: 10.1016/j.talanta.2017.03.027. Epub 2017 Mar 9.

PMID:
28391830
5.

Cytokines associated with increased erythropoiesis in Sprague-Dawley rats administered a novel hyperglycosylated analog of recombinant human erythropoietin.

Andrews DA, Hamadeh HK, He YD, Boren BM, Turk JR, Boyce RW, Mytych DT, Barger TE, Salimi-Moosavi H, Sloey B, Elliott S, McElroy P, Sinclair AM, Shimamoto G, Pyrah IT, Lightfoot-Dunn RM.

Toxicol Pathol. 2014;42(3):540-54. doi: 10.1177/0192623313486318. Epub 2013 May 14.

PMID:
23674392
6.

Dose-related differences in the pharmacodynamic and toxicologic response to a novel hyperglycosylated analog of recombinant human erythropoietin in Sprague-Dawley rats with similarly high hematocrit.

Andrews DA, Boren BM, Turk JR, Boyce RW, He YD, Hamadeh HK, Mytych DT, Barger TE, Salimi-Moosavi H, Sloey B, Elliott S, McElroy P, Sinclair AM, Shimamoto G, Pyrah IT, Lightfoot-Dunn RM.

Toxicol Pathol. 2014;42(3):524-39. doi: 10.1177/0192623313486319. Epub 2013 May 14.

PMID:
23674391
7.

Peptibodies: A flexible alternative format to antibodies.

Shimamoto G, Gegg C, Boone T, Quéva C.

MAbs. 2012 Sep-Oct;4(5):586-91. doi: 10.4161/mabs.21024. Epub 2012 Jul 23. Review.

8.

Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2-neutralizing peptibody.

Coxon A, Bready J, Min H, Kaufman S, Leal J, Yu D, Lee TA, Sun JR, Estrada J, Bolon B, McCabe J, Wang L, Rex K, Caenepeel S, Hughes P, Cordover D, Kim H, Han SJ, Michaels ML, Hsu E, Shimamoto G, Cattley R, Hurh E, Nguyen L, Wang SX, Ndifor A, Hayward IJ, Falcón BL, McDonald DM, Li L, Boone T, Kendall R, Radinsky R, Oliner JD.

Mol Cancer Ther. 2010 Oct;9(10):2641-51. doi: 10.1158/1535-7163.MCT-10-0213.

9.

Co-receptor requirements for fibroblast growth factor-19 signaling.

Wu X, Ge H, Gupte J, Weiszmann J, Shimamoto G, Stevens J, Hawkins N, Lemon B, Shen W, Xu J, Veniant MM, Li YS, Lindberg R, Chen JL, Tian H, Li Y.

J Biol Chem. 2007 Oct 5;282(40):29069-72. Epub 2007 Aug 21.

10.

Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic effects on cortical and cancellous bone.

Kostenuik PJ, Ferrari S, Pierroz D, Bouxsein M, Morony S, Warmington KS, Adamu S, Geng Z, Grisanti M, Shalhoub V, Martin S, Biddlecome G, Shimamoto G, Boone T, Shen V, Lacey D.

J Bone Miner Res. 2007 Oct;22(10):1534-47.

11.

OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats.

Kostenuik PJ, Capparelli C, Morony S, Adamu S, Shimamoto G, Shen V, Lacey DL, Dunstan CR.

Endocrinology. 2001 Oct;142(10):4295-304.

PMID:
11564687
12.

Characterization of osteoclast precursors in human blood.

Shalhoub V, Elliott G, Chiu L, Manoukian R, Kelley M, Hawkins N, Davy E, Shimamoto G, Beck J, Kaufman SA, Van G, Scully S, Qi M, Grisanti M, Dunstan C, Boyle WJ, Lacey DL.

Br J Haematol. 2000 Nov;111(2):501-12.

PMID:
11122091
13.

Development of disulfide peptide mapping and determination of disulfide structure of recombinant human osteoprotegerin chimera produced in Escherichia coli.

Merewether LA, Le J, Jones MD, Lee R, Shimamoto G, Lu HS.

Arch Biochem Biophys. 2000 Mar 1;375(1):101-10.

PMID:
10683254
14.

A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.

Morony S, Capparelli C, Lee R, Shimamoto G, Boone T, Lacey DL, Dunstan CR.

J Bone Miner Res. 1999 Sep;14(9):1478-85.

15.

Interaction of granulocyte colony-stimulating factor (G-CSF) with its receptor. Evidence that Glu19 of G-CSF interacts with Arg288 of the receptor.

Layton JE, Shimamoto G, Osslund T, Hammacher A, Smith DK, Treutlein HR, Boone T.

J Biol Chem. 1999 Jun 18;274(25):17445-51.

16.

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ.

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3540-5.

17.

Chemical modification and site-directed mutagenesis of methionine residues in recombinant human granulocyte colony-stimulating factor: effect on stability and biological activity.

Lu HS, Fausset PR, Narhi LO, Horan T, Shinagawa K, Shimamoto G, Boone TC.

Arch Biochem Biophys. 1999 Feb 1;362(1):1-11.

PMID:
9917323
18.

Comparison of solution properties of human and rat ciliary neurotrophic factor.

Narhi LO, Rosenfeld R, Shimamoto G, Lee R, Hawkins N, Li T, Philo J, Wen J, Arakawa T.

J Pept Res. 1997 Oct;50(4):300-9.

PMID:
9352468
19.

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ.

Cell. 1997 Apr 18;89(2):309-19.

20.

Glial cell line-derived neurotrophic factor: selective reduction of the intermolecular disulfide linkage and characterization of its disulfide structure.

Haniu M, Hui J, Young Y, Le J, Katta V, Lee R, Shimamoto G, Rohde MF.

Biochemistry. 1996 Dec 24;35(51):16799-805.

PMID:
8988018
21.

Destripeptide insulin-like growth factor-I in milk from bovine somatotropin-treated cows.

Shimamoto GT, Byatt JC, Jennings MG, Comens-Keller PG, Collier RJ.

Pediatr Res. 1992 Sep;32(3):296-300.

PMID:
1408465
22.

Trypanosoma congolense: structure and molecular organization of the surface glycoproteins of two early bloodstream variants.

Strickler JE, Binder DA, L'Italien JJ, Shimamoto GT, Wait SW, Dalheim LJ, Novotny J, Radding JA, Konigsberg WH, Armstrong MY, et al.

Biochemistry. 1987 Feb 10;26(3):796-805.

PMID:
3567147
24.

Trypanosome variant-specific glycoproteins: a polygene protein family with multiple folding patterns?

Lalor TM, Kjeldgaard M, Shimamoto GT, Strickler JE, Konigsberg WH, Richards FF.

Proc Natl Acad Sci U S A. 1984 Feb;81(4):998-1002.

25.

Taurine catabolism. III. Evidence for the participation of the glyoxylate cycle.

Shimamoto G, Berk RS.

Biochim Biophys Acta. 1980 Oct 15;632(3):399-407.

PMID:
6774766
26.

Taurine catabolism. II. biochemical and genetic evidence for sulfoacetaldehyde sulfo-lyase involvement.

Shimamoto G, Berk RS.

Biochim Biophys Acta. 1980 Sep 17;632(1):121-30.

PMID:
6251906
27.

Catabolism of taurine in Pseudomonas aeruginosa.

Shimamoto G, Berk RS.

Biochim Biophys Acta. 1979 Aug 15;569(2):287-92.

PMID:
113035
28.

Pathway of galactitol catabolism in Klebsiella pneumoniae.

Markwell J, Shimamoto GT, Bissett DL, Anderson RL.

Biochem Biophys Res Commun. 1976 Jul 12;71(1):221-7. No abstract available.

PMID:
134705

Supplemental Content

Loading ...
Support Center